Merck (MRK) reported Q3 FY 2017 earnings of $1.11 per share (versus $1.07 in Q3 FY 2016), beating analysts' consensus estimate of $1.03.
The company's quarterly revenues amounted to $10.325 bln (-2.0% y/y), missing analysts' consensus estimate of $10.545 bln.
MRK fell to $60.92 (-1.73%) in pre-market trading.